IDAHealth — Guided Compression, measured Patent Hemostasis
IDAHealth Inc. is a medical device company building the measurement layer for a standard every major cardiology society already recommends: Patent Hemostasis after transradial cardiac catheterization. Its product, IdaFlo TR, is a single-use wristband that continuously measures radial artery blood flow during post-procedural compression, positioned distal to any existing compression band.
The clinical access route is solved; the compression that follows is still done without measurement. Patent Hemostasis, keeping the artery open throughout compression, is endorsed worldwide but achieved inconsistently, because until now no device measured it continuously. IdaFlo TR provides that measurement in real time, so compression is guided by continuous data rather than intermittent manual checks.
IdaFlo TR is built on IdaSense conductive-elastomer sensing. IDAHealth was named to the 2026 BDMT Global Top 40 Global Innovations List. Founder and CEO: David L. Camp, Jr. Medical Director: Dr. Giovanni Amoroso (OLVG Hospital).